Results 201 to 210 of about 427,029 (392)

Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinib [PDF]

, 2014
X-D Mo, Qian Jiang, L-P Xu, D-H Liu, K Y Liu, Bo Jiang, Hongchao Jiang, Y-H. Chen, Yen‐Hsu Chen, Zhang Xiu, Wei Han, Yibin Wang, Xiao‐Jun Huang   +12 more
openalex   +1 more source

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

ESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo, Daniela Di Lisi, Antonio Cannatà, Federica Manfrè, Celeste Vullo, Marco Santoro, Ciro Botta, Salvatrice Mancuso, Sergio Siragusa, Alfredo Ruggero Galassi, Giuseppina Novo   +10 more
wiley   +1 more source

Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.

Blood reviews, 2021
A. Osman, M. Deininger
semanticscholar   +1 more source

One‐Stone‐Two‐Birds Carrier‐Free Nano‐Cocktail Enables Synergistic Eradication of Cancer Cells/Stem Cells in Breast Cancer Treatment

Exploration, EarlyView.
ABSTRACT Cancer stem cells (CSCs) are widely recognized as the culprits of chemoresistance, tumor metastasis, and relapse. Moreover, most chemotherapeutic drugs not only fail to eliminate CSCs effectively, but also induce the acquisition of stemness characteristics in non‐stem cancer cells. Herein, we propose a cancer cells/CSCs double‐killing modality
Tongyao Zhao, Yao Chen, Haimeng Yuan, Shuqian Yang, Hongyuan Zhang, Yuequan Wang, Shenwu Zhang, Qin Chen, Jin Sun, Zhonggui He, Cong Luo   +10 more
wiley   +1 more source

How we will treat chronic myeloid leukemia in 2016

, 2014
Chetasi Talati, Evelena P. Ontiveros, Elizabeth A. Griffiths, Eunice S. Wang, Meir Wetzler   +4 more
openalex   +1 more source

Canned Foods: Evolution, Benefits, and Health Implications of Modern Packaging

Food Safety and Health, EarlyView.
This graphical abstract presents a concise visual overview of canned food technology, highlighting its historical evolution, key benefits, and associated health risks. It integrates timelines, icons, and summary points to clearly communicate advancements in preservation, consumer advantages, and potential safety concerns in a single schematic ...
Shaswati Rout, Priyadarsini Sahoo, Anuprita Ray, Shuvendu Shekhar Mohapatra   +3 more
wiley   +1 more source

Imatinib‐induced psoriasiform eruption in a patient with chronic myeloid leukemia [PDF]

, 2017
Connie R. Shi, Vinod E. Nambudiri
openalex   +1 more source

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.

Journal of Clinical Oncology, 2016
J. Cortes, G. Saglio, H. Kantarjian, M. Baccarani, J. Mayer, C. Boqué, N. Shah, C. Chuah, L. Casanova, Brigid Bradley-Garelik, G. Manos, A. Hochhaus   +11 more
semanticscholar   +1 more source

Subsequential Alterations of Telomeric DNA Length Correlate with Cytogenetic Response in Chronic Myeloid Leukemia Treated with Interferon alpha [PDF]

, 1999
Shigefumi Hayashi, Hiroshi Iwama, Naoyuki Yahata, Keiko Ando, Junko H. Ohyashiki, Kazuma Ohyashiki   +5 more
openalex   +1 more source

Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience

, 2022
Elżbieta Szczepanek, Ositadima Chukwu, Magdalena Kamińska, Hubert Wysogląd, Agnieszka Cenda, Magdalena Zawada, Małgorzata Jakóbczyk, Joanna Wącław, Tomasz Sacha   +8 more
openalex   +2 more sources